BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2573370)

  • 1. Antihypertensive action of beta-adrenoceptor blocking drugs. The role of intrarenal mechanisms.
    Struyker-Boudier HA; Smits JF
    Am J Hypertens; 1989 Nov; 2(11 Pt 2):237S-240S. PubMed ID: 2573370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereospecificity of beta-adrenoceptor blockade and renal vasodilatation by tertatolol.
    Smits JF; Zeegers HH; Struyker-Boudier HA
    Arch Int Pharmacodyn Ther; 1989; 298():164-71. PubMed ID: 2569294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term renal vasodilator effect of the beta-adrenoceptor blocker tertatolol in conscious spontaneously hypertensive rats.
    Nievelstein HN; Tyssen CM; Smits JF; Struyker-Boudier HA
    J Cardiovasc Pharmacol; 1988 Aug; 12(2):252-4. PubMed ID: 2459558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in renal hemodynamics during chronic and acute beta-blockade in humans.
    Beaufils M
    Am J Hypertens; 1989 Nov; 2(11 Pt 2):233S-236S. PubMed ID: 2573369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal hemodynamic effects of tertatolol in essential hypertension.
    Paillard F; Lantz B; Leviel F; Ardaillou R
    Am J Nephrol; 1986; 6 Suppl 2():40-4. PubMed ID: 2879472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological features of the vasodilation induced by tertatolol in isolated perfused rat kidneys.
    Verbeuren TJ; Herman AG
    Am J Hypertens; 1989 Nov; 2(11 Pt 2):219S-222S. PubMed ID: 2573367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the antihypertensive and renal effects of tertatolol and nadolol in hypertensive patients with mild renal impairment.
    Fallo F; Gregianin M; Bui F; Macrì C; Folino P; Mantero F
    Eur J Clin Pharmacol; 1991; 40(3):309-11. PubMed ID: 1676368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive and renal effects of tertatolol, a new beta-blocking agent, in hypertensive patients.
    Salvetti A; Leonetti G; Bernini GP; Rupoli L; Lucarini AR; Sangiorgio P; Mauro M; Di Stratis P; Zanchetti A
    Am J Nephrol; 1986; 6 Suppl 2():45-9. PubMed ID: 2879473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prejunctional beta-adrenoceptors in the isolated perfused rat kidney: a comparative study of the beta-blockers tertatolol and propranolol.
    Verbeuren TJ; Zonnekeyn LL; Prost JF; Herman AG
    Arch Int Pharmacodyn Ther; 1989; 298():183-97. PubMed ID: 2569296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta blockers induce different intrarenal effects in humans: demonstration by selective infusion of tertatolol and propranolol.
    Nitenberg A; Chemla D; Blanchet F; Guery O; Prost JF; Dutray-Dupagne C
    J Clin Pharmacol; 1990 Oct; 30(10):930-7. PubMed ID: 1977772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overview of novel renal properties of tertatolol.
    Guillet C
    Cardiology; 1993; 83 Suppl 1():64-9. PubMed ID: 7903218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Tertatolol--characteristics of the drug].
    Tomaszewski R; Kliz J
    Wiad Lek; 1992 Mar; 45(5-6):196, 200, 204 passim. PubMed ID: 1360731
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of tertatolol on renal function in the isolated perfused rat kidney.
    Perico N; Remuzzi G
    Am J Hypertens; 1989 Nov; 2(11 Pt 2):223S-227S. PubMed ID: 2573368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Renal effects of intravenous tertatolol in essential arterial hypertension].
    Chaignon M; Brouard R; Lucsko M; Guédon J
    Arch Mal Coeur Vaiss; 1990 Jul; 83(8):1219-22. PubMed ID: 1979729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tertatolol ameliorates renal function in rats with chronic renal failure.
    Delaini F; Perico N; Tagliaferri M; Lupini C; Patino O; Remuzzi G; Garattini S
    J Pharmacol Exp Ther; 1988 Jul; 246(1):287-93. PubMed ID: 2899165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal and systemic effects of atenolol and tertatolol in renal transplant recipients on cyclosporine A.
    Branten AJ; Hilbrands LB; van Hamersvelt HW; Koene RA; Huysmans FT
    Nephrol Dial Transplant; 1998 Feb; 13(2):423-6. PubMed ID: 9509456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal hemodynamic effects of tertatolol compared with those of propranolol in the conscious dog.
    Laubie M; Prost JF; Rochat C
    Am J Nephrol; 1986; 6 Suppl 2():20-4. PubMed ID: 2879468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional hemodynamic effects of the beta-adrenoceptor blockers tertatolol and propranolol in conscious spontaneously hypertensive rats.
    Nievelstein HM; Tijssen CM; Smits JF; Struyker-Boudier HA
    Arch Int Pharmacodyn Ther; 1986 Jul; 282(1):118-29. PubMed ID: 2876684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of tertatolol in hypertensive patients with chronic renal failure.
    Beaufils M; Lantz B; Paillard F; Richet G
    Am J Nephrol; 1986; 6 Suppl 2():50-4. PubMed ID: 2879474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The beta adrenoceptor blocker tertatolol causes vasodilatation in the isolated perfused vasoconstricted rat kidney.
    Verbeuren TJ; Zonnekeyn LL; Prost JF; Rochat C; Thomas JR; Herman AG
    J Pharmacol Exp Ther; 1988 Aug; 246(2):628-34. PubMed ID: 2900328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.